Meral Beksac, MD, Ankara University, Ankara, Turkey, comments on sensitivity to treatment in patients with multiple myeloma with extramedullary disease (EMD), highlighting the criteria for complete response in this patient population. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.